It is now well documented that peptides with enhanced or alternative functionality (termed
cryptides) can be liberated from larger, and sometimes inactive, proteins. A primary example …

While native blood group A‐like glycans have not been demonstrated in prokaryotic
microorganisms as a source of human “natural” anti‐A isoagglutinin production, and …

Background Aquaculture production is expected to double by 2030, and demands for
aquafeeds and raw materials are expected to increase accordingly. Sustainable growth of …

Background: Recently, we produced a tumour antigen-presenting cells (TAPCells) vaccine
using a melanoma cell lysate, called TRIMEL, as an antigen source and an activation factor …

This comprehensive volume provides a plethora of first-hand information on the diversity,
biology, and ecology of edible marine bivalve molluscs. It covers the biology of edible …

Hemocyanins, the huge oxygen-transporting glycoproteins of some mollusks, are used as
immunomodulatory proteins with proven anti-cancer properties. The biodiversity of …

Hemocyanins induce a potent Th1-dominant immune response with beneficial clinical
outcomes when used as a carrier/adjuvant in vaccines and nonspecific immunostimulant in …

Background Immune checkpoint blocker (ICB) therapy has shown survival benefits for some
patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance …

Mollusk hemocyanins have been used for decades in immunological and clinical
applications as natural, nontoxic, nonpathogenic, and nonspecific immunostimulants for the …

This study is the first report describing the promising antitumor activity of biologically active
compounds isolated from the hemolymph of marine snail Rapana venosa—a fraction with …